Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A
J.R. Horton, Xu Liu, Lizhen Wu, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 7, pp. 3193-3208
Open Access | Times Cited: 12

Showing 12 citing articles:

KDM5 histone demethylases repress immune response via suppression of STING
Lizhen Wu, Jian Cao, Wesley L. Cai, et al.
PLoS Biology (2018) Vol. 16, Iss. 8, pp. e2006134-e2006134
Open Access | Times Cited: 140
Chiral Recognition of CIAC001 Isomers in Regulating Pyruvate Kinase M2 and Mitigating Neuroinflammation
Sha Jin, Xue Wang, Xin Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117262-117262
Closed Access | Times Cited: 1
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Yi Zhang, Deqin Rong, Bingbing Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7900-7925
Closed Access | Times Cited: 38
Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy
Yuka Miyake, Yukihiro Itoh, Atsushi Hatanaka, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 6, pp. 1119-1129
Open Access | Times Cited: 32
Increasing the Efficacy of Seproxetine as an Antidepressant Using Charge–Transfer Complexes
Walaa F. Alsanie, Abdulhakeem S. Alamri, Hussain Alyami, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3290-3290
Open Access | Times Cited: 17
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
J.R. Horton, Clayton B. Woodcock, Qin Chen, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 23, pp. 10588-10601
Open Access | Times Cited: 32
KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
Shang‐Min Zhang, Jian Cao, Qin Yan
Advances in experimental medicine and biology (2023), pp. 113-137
Closed Access | Times Cited: 1
Histone Demethylases
Stephen C. Kales, Anton Simeonov
Royal Society of Chemistry eBooks (2024), pp. 383-403
Closed Access
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets

Royal Society of Chemistry eBooks (2024)
Closed Access
Inhibitors of JmjC-Containing Histone Demethylases
Miranda Wright, Paul E. Brennan, Akane Kawamura
Topics in medicinal chemistry (2019), pp. 221-253
Closed Access | Times Cited: 1
Inhibitors of Jumonji-C domain-containing histone demethylases
Veronica Sian, José A. Souto, Rosana Álvarez, et al.
Elsevier eBooks (2023), pp. 407-457
Closed Access
IN SILICO STUDIES FOR BIOACTIVE PROPOSAL AGAINST HUMAN RETINOBLASTOMA FROM 3,4,5-TRIHYDROXYCINAMIC ACID DERIVATIVES
Alex Monteiro, Natália Ferreira de Sousa, Érika Paiva de Moura, et al.
Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition (2019), pp. 6718-6718
Open Access
Page 1

Scroll to top